Discontinuation report STRATTERA

Last updated on 2022-10-11 History
Report ID 171488
Drug Identification Number 02262835
Brand name STRATTERA
Common or Proper name atomoxetine capsules
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) ATOMOXETINE
Strength(s) 40MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size Blister package of 28 capsules
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2023-03-01
Actual discontinuation date
Remaining supply date 2023-03-01
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Anticipated remaining supply date may be impacted based on any changes in demand.
Company comments For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-10-11 French Compare
v1 2022-10-11 English Compare

Showing 1 to 2 of 2